Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format: Artigo
Langue:Russo
Publié: «FIRMA «SILICEA» LLC 2004-12-01
Collection:Российский кардиологический журнал
Sujets:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Accès en ligne:https://russjcardiol.elpub.ru/jour/article/view/2326
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires